Clinical implications of altered drug transporter abundance/function and PBPK modeling in specific populations: An ITC perspective

Xiaoyan Chu, Bhagwat Prasad, Sibylle Neuhoff, Kenta Yoshida, J. Steven Leeder, Dwaipayan Mukherjee, Kunal Taskar, Manthena V. Varma, Xinyuan Zhang, Xinning Yang, Aleksandra Galetin

Pharmacy

Merck & Co Inc
Washington State University
Certara UK Limited
Genentech Inc
Children's Mercy Hospital
AbbVie Inc
GlaxoSmithKline
Pfizer Inc
US Food and Drug Administration (FDA)

Research output: Contribution to journal › Article › peer-review

399 Downloads (Pure)

1 results
- Title(descending)

Biological Mass Spectrometry (BioMS) Facility
Knight, D. (Core Facility Lead), Warwood, S. (Senior Technical Specialist), Selley, J. (Technical Specialist), Taylor, G. (Technical Specialist), Fullwood, P. (Technical Specialist), Keevill, E.-J. (Senior Technician) & Allsey, J. (Technician)
FBMH Platform Sciences, Enabling Technologies & Infrastructure
Facility/equipment: Facility

Clinical implications of altered drug transporter abundance/function and PBPK modeling in specific populations: An ITC perspective

Equipment

Search results

Biological Mass Spectrometry (BioMS) Facility